DuraStat, a medical device company for surgical tissue closure, has received an innovative technology contract from healthcare performance improvement company Vizient.
The agreement will expedite access to DuraStat’s flagship technology, a dural repair device for spine and neurosurgery, across Vizient’s membership of hospitals and surgery centers.
Innovative technology contracts are recommended after review and interaction with products submitted through Vizient’s Innovative Technology Program. Vizient member-led councils identify technologies that have the potential to enhance clinical care, patient safety, health care worker safety or improve business operations of health care organizations.
“We’re honored by the recognition — the tremendous credibility and reach of Vizient aligns with DuraStat’s mission to be available at every spine facility,” says Adam Azzara, DuraStat CEO.
Vizient’s membership base includes academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks and non-acute health care providers and represents more than $130 billion in annual purchasing volume.
“A product receives this type of contract when it demonstrates a unique quality that differentiates it from other products on the market,” says Kelly Flaharty, director of contract process for Vizient. “Our member council determined that DuraStat’s dural repair device for spine and neurosurgery met this standard and recognizes its potential to improve quality outcomes.”
Through its Innovative Technology Program, Vizient works with member-led councils and task forces to evaluate products for their potential to bring real innovation to health care. Vizient may award a contract to products deemed worthy of the Innovative Technology designation outside of the competitive bid cycle.
Photo: DuraStat Awarded Innovative Technology Designation.
